CBT for Problematic Impulsive Behaviours in Bipolar Disorder: A Case Series / CBT-PIB

NCT06129500 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2025-04-30

No results posted yet for this study

Summary

The goal of this case series is to explore whether a talking therapy, specifically Cognitive Behavioural Therapy (CBT) is acceptable and feasible in the management of mood-driven impulsive behaviours in people with bipolar disorder (BD).

The main questions it aims to answer are:

* Whether CBT Is a feasible intervention for participants with BD who report mood-driven, problematic impulsive behaviours.
* Whether CBT for mood-driven, problematic impulsive behaviours (CBT-PIB) is acceptable to service users with BD and therapists.
* Whether clinical outcomes are consistent with the potential for this novel intervention to offer clinical benefit to participants with BD.

The study also hopes to:

* conduct a preliminary examination of the safety of CBT-PIB and the research procedures.
* gather information on the potential mechanisms of action of CBT-PIB and,
* gather information on the types of mood-driven impulsive behaviours individuals with BD may seek support for.

Participants will:

* be offered up to 12 individual sessions of CBT focusing on mood-driven impulsive behaviours.
* be asked to complete a battery of self-report measures (5) when they enter the study and at the start and end of treatment.
* be asked to track mood and impulsive behaviours by completing a brief set of measures (3) weekly during the two-week baseline phase, the intervention phase and the 2-week post-intervention phase.
* be asked to complete a survey on the acceptability of the intervention and
* be invited to an optional semi-structured interview on their research experience.

Conditions

Interventions

BEHAVIORAL

Cognitive Behavioural Therapy for Problematic Impulsive Behaviours

Up to 12 sessions of Cognitive Behavioural Therapy adapted to focus on mood-driven impulsivity in adults with bipolar disorder.

Sponsors & Collaborators

  • Southern Health NHS Foundation Trust

    collaborator OTHER
  • Somerset NHS Foundation Trust

    collaborator OTHER
  • Devon Partnership NHS Trust

    collaborator OTHER_GOV
  • University of Exeter

    lead OTHER

Principal Investigators

  • Jan Freeman, MSc · University of Exeter

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-17
Primary Completion
2026-09-10
Completion
2027-01-24

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06129500 on ClinicalTrials.gov